) has been revised to $6.80 / share. This is a decrease of 11.11% from the prior estimate of $7.65 dated February 1, 2026. The price target is an average of many targets provided by analysts. The ...

) has been revised to $7.65 / share. This is an increase of 12.50% from the prior estimate of $6.80 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

As of 24 August at 3:57:41 pm GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Microbot Medical Inc. (MBOT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.